Myotoxic effects of levobupivacaine, bupivacaine and ropivacaine in a rat model
Author(s) -
Karamehmet Yıldız,
Sukran Nergiz Efesoy,
Saim Özdamar,
Arzu Yay,
Cihangir Biçer,
Recep Aksu,
Eser Kılıç
Publication year - 2011
Publication title -
clinical and investigative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 47
eISSN - 1488-2353
pISSN - 0147-958X
DOI - 10.25011/cim.v34i5.15670
Subject(s) - levobupivacaine , ropivacaine , bupivacaine , medicine , anesthesia
Aim: The aim of this study is to histopathalogically compare the myotoxic effects of a single injection of levobupivacaine, bupivacaine and ropivacaine in rat skeletal muscle.Materials and Methods: Rats received intramuscular injections of 0.5% bupivacaine (Group B), 0.5% ropivacaine (Group R), 0.5% levobupivacaine (Group L), or 0.9% normal saline (Group SF) (30 rats/group). At two, 10 and 20 days, 10 rats from each group were sacrificed and muscle samples were examined for myotoxic effects using hematoxylin-eosin staining under a light microscope.Results: Muscle damage in Groups B, L and R was similar qualitatively. In samples taken two days after injection, the muscle damage in Group B was maximal [Damage score: 3.0 (2.0-3.0)], Group R had less damage than Group B [damage score: 2.0 (2.0-3.0)] and the damage in Group L was minimal [Damage score: 1.0 (1.0-2.0)]. In muscle samples taken 10 days after injection, there was no significant difference in muscle damage scores among Groups B, R and L. In muscle samples taken 20 days after injection, regeneration was complete, and muscle mass was histologically normal for each of the three groups (B, L and R). Conclusion: Levobupivacaine’s myotoxic effect is qualitatively similar to that seen (and previously reported) with bupivacaine and ropivacaine. Levobupivacaine was found to be quantitatively less myotoxic than bupivacaine and ropivacaine after a single intramuscular injection, only two days after injection. Myonecrosis developed after a single intramuscular injection of local anesthetic but was completely regenerated by the 20th day after injection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom